|
CA2793129A1
|
|
Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
|
|
WO2011006903A1
|
|
Substituted triazole and imidazole derivatives as gamma secretase modulators
|
|
NZ594309A
|
|
Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
|
|
UA104746C2
|
|
Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
|
|
WO2010031832A2
|
|
Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
|
|
TW201023858A
|
|
Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
|
|
CN101801930A
|
|
1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
|
|
CN103342695A
|
|
1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones
|
|
NZ579986A
|
|
3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
|
|
NZ579989A
|
|
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
|
|
CN101400654A
|
|
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
|
|
EP1392326A1
|
|
Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
|
